Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin ii by H2O2 in red blood cells

Antioxidants and Redox Signaling

Volumn 12, Issue 11, 2010, Pages 1235-1246

  Cho, Chun Seok ^a,b   Lee, Sukmook ^a   Lee, Geun Taek ^a   Woo, Hyun Ae ^a   Choi, Eui Ju ^b   Rhee, Sue Goo ^a  

^a Ewha Womans University   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYSTEINE SULFINIC ACID; DEHYDROALANINE; GLUTATHIONE PEROXIDASE 1; HEMOGLOBIN; HYDROGEN PEROXIDE; OXIDOREDUCTASE; PEROXIREDOXIN 2; SELENOCYSTEINE; SULFIREDOXIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOOXIDATION; BIOTRANSFORMATION; CATALYSIS; CELL DENSITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ALANINE; BIOCATALYSIS; CATALYTIC DOMAIN; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MASS SPECTROMETRY; OXIDATION-REDUCTION; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PEROXIREDOXINS;

EID: 77951813369     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2701     Document Type: Article

References (48)

1. Andersen HR, Nielsen JB, Nielsen F, and Grandjean P. An-tioxidative enzyme activities in human erythrocytes. Clin Chem 43: 562-568, 1997.
2. Awasthi YC, Beutler E, and Srivastava SK. Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem 250: 5144-5149, 1975.
3. Bartosz, G. Aging of the erythrocyte. VII. On the possible causes of inactivation of red cell enzymes. Mech Ageing Dev 13: 379-385, 1980.
4. Beutler, E. The hemolytic effect of primaquine and related compounds: A review. Blood 14: 103-139, 1959.
5. Biteau B, Labarre J, and Toledano MB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphir-edoxin. Nature 425: 980-984, 2003.
6. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Haf-ner G, Tiret L, Smieja M, Cambien F, Meyer J, and Lackner KJ. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349: 1605-1613, 2003.
7. Blum J and Fridovich I. Inactivation of glutathione peroxi-dase by superoxide radical. Arch Biochem Biophys 240: 500-508, 1985.
8. Boyer C, Kahn A, Cottreau D, and Marie J. [Mechanism of decrease in erythrocyte enzyme activities during red cell aging in the newborn and the adult]. Nouv Rev Fr Hematol Blood Cells 18: 229-231, 1977.
9. Brigelius-Flohe, R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27: 951-965, 1999.
10. Chae HZ, Chung SJ, and Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269: 27670-27678, 1994.
11. Chae HZ, Robison K, Poole LB, Church G, Storz G, and Rhee SG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA 91: 7017-7021, 1994.
12. Dincer Y, Akcay T, Alademir Z, and Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 51: 1360-1362, 2002.
13. Flohe L and Brigelius-Flohe R. Selenoproteins of the gluta-thione system. In: Selenium. Its Molecular Biology and Role in Human Health, edited by Hatfield, dl. Boston, Dordrecht, London: Kluwer Academic Publishers. 2001. pp. 161-172
14. Hamann M, Zhang T, Hendrich S, and Thomas JA. Quan-titation of protein sulfinic and sulfonic acid, irreversibly oxidized protein cysteine sites in cellular proteins. Methods Enzymol 348: 146-156, 2002.
15. Harrison JH, Jr. and Jollow DJ. Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther 238: 1045-1054, 1986.
16. Ho YS, Magnenat JL, RBronson RT, Cao J, Gargano M, Sugawara M, and Funk CD. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272: 16644-16651, 1997.
17. Ho YS, Xiong Y, Ma W, Spector A, and Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279: 32804-32812, 2004.
18. Jacob HS, Ingbar SH, and Jandl JH. Oxidative hemolysis and erythrocyte metabolism in hereditary acatalasia. J Clin Invest 44: 1187-1199, 1965.
19. Jeong W, Park SJ, Chang TS, Lee DY, and Rhee SG. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J Biol Chem 281: 14400-14407, 2006.
20. Johnson RM, Goyette G Jr, Ravindranath Y, and Ho YS. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med 39: 1407-1417, 2005.
21. Johnson RM, Goyette G Jr, Ravindranath Y, and Ho YS. Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood 96: 1985-1988, 2000.
22. Lee TH, Kim SU, Yu SL, Kim SH, Park DS, Moon HB, Dho SH, Kwon KS, Kwon HJ, Han YH, Jeong S, Kang SW, Shin HS, Lee KK, Rhee SG, and Yu DY. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038, 2003.
23. Low FM, Hampton MB, Peskin AV, and Winterbourn CC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109: 2611-2617, 2007.
24. Low FM, Hampton MB, and Winterbourn CC. Peroxir-edoxin 2 and peroxide metabolism in the erythrocyte. Anti-oxid Redox Signal 10: 1621-1630, 2008.
25. Ma S, Caprioli RM, Hill KE, and Burk RF. Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom 14: 593-600, 2003.
26. Margoliash E, Novogrodsky A, and Schejter A. Irreversible reaction of 3-amino-1:2:4-triazole and related inhibitors with the protein of catalase. Biochem J 74: 339-348, 1960.
27. Marzocchi B, Ciccoli L, Tani C, Leoncini S, Rossi V, Bini L, Perrone S, and Buonocore G. Hypoxia-induced post-trans-lational changes in red blood cell protein map of newborns. Pediatr Res 58: 660-665, 2005.
28. Moore RB, Mankad MV, Shriver SK, Mankad VN, and Plishker GA. Reconstitution of Ca(2\+)-dependent K\+ transport in erythrocyte membrane vesicles requires a cyto-plasmic protein. J Biol Chem 266: 18964-18968, 1991.
29. Ninfali P, Palma F, Baronciani L, and Piacentini G. Glucose-6-phosphate dehydrogenase activity and protein turnover in erythroblasts separated by velocity sedimentation at unit gravity and Percoll gradient centrifugation. Mol Cell Biochem 106: 151-160, 1991.
30. Palacios O and Lobinski R. Investigation of the stability of selenoproteins during storage of human serum by size-exclusion LC-ICP-MS. Talanta 71: 1813-1816, 2007.
31. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, and Winterbourn CC. The high reactivity of peroxiredoxin 2 with H2O2 is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 282: 11885-11892, 2007.
32. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, and Remacle J. Glutathione peroxi-dase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 51: 283-297, 1990.
33. Rhee SG, Kang SW, Chang TS, Jeong W, and Kim K. Per-oxiredoxin, a novel family of peroxidases. IUBMB Life 52: 35-41, 2001.
34. Rifkind JM, Ramasamy S, Manoharan PT, Nagababu E, and Mohanty JG. Redox reactions of hemoglobin. Antioxid Redox Signal 6: 657-666, 2004.
35. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, and Hoekstra WG. Selenium: Biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
36. Rundlof AK and Arner ES. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid Redox Signal 6: 41-52, 2004.
37. Salvo GP, Caprari P, Samoggia P, Mariani G, and Salvati AM. Human erythrocyte separation according to age on a discontinuous "Percoll" density gradient. Clin Chim Acta 122: 293-300, 1982.
38. Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, Bickel C, Cambien F, Tiret L, Munzel T, and Blankenberg S. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: Results from the AtheroGene study. J Am Coll Cardiol 45: 1631-1637, 2005.
39. Seo J, Jeong J, Kim YM, Hwang N, Paek E, and Lee KJ. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase. J Proteome Res 7: 587-602, 2008.
40. Singh H, Purnell E, and Smith C. Mechanistic study on aniline-induced erythrocyte toxicity. Arh Hig Rada Toksikol 58: 275-285, 2007.
41. Wendel A, Pilz W, Ladenstein R, Sawatzki G, and Weser U. Substrate-induced redox change of selenium in glutathione peroxidase studied by X-ray photoelectron spectroscopy. Biochim Biophys Acta 377: 211-215, 1975.
42. Winterbourn CC. Free-radical production and oxidative reactions of hemoglobin. Environ Health Perspect 64: 321-330, 1985.
43. Winterbourn CC, McGrath BM, and Carrell RW. Reactions involving superoxide and normal and unstable haemoglobins. Biochem J 155: 493-502, 1976.
44. Winterbourn CC and Stern A. Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 80: 1486-1491, 1987.
45. Wolff SS. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol 233: 182-189, 1994.
46. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, and Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.
47. Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, and Rhee SG. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 280: 3125-3128, 2005.
48. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, and Rhee SG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277: 38029-38036, 2002